LIMP-2 expression is critical for -glucocerebrosidase activity and -synuclein clearance
出版年份 2014 全文链接
标题
LIMP-2 expression is critical for -glucocerebrosidase activity and -synuclein clearance
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 43, Pages 15573-15578
出版商
Proceedings of the National Academy of Sciences
发表日期
2014-10-15
DOI
10.1073/pnas.1405700111
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
- (2014) Karen E. Murphy et al. BRAIN
- Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
- (2014) Jose Bras et al. HUMAN MOLECULAR GENETICS
- Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease
- (2013) Laura D. Osellame et al. Cell Metabolism
- Is Parkinson disease associated with lysosomal integral membrane protein type-2?: Challenges in interpreting association data
- (2013) Emerson Maniwang et al. MOLECULAR GENETICS AND METABOLISM
- Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction
- (2013) Edward I. Ginns et al. MOLECULAR GENETICS AND METABOLISM
- The role ofSCARB2as susceptibility factor in Parkinson's disease
- (2013) Franziska Hopfner et al. MOVEMENT DISORDERS
- Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36
- (2013) Dante Neculai et al. NATURE
- The role of autophagy in neurodegenerative disease
- (2013) Ralph A Nixon NATURE MEDICINE
- Progressive myoclonus epilepsy: extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novelSCARB2mutations
- (2013) Yong-Juan Fu et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
- (2013) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies
- (2013) Karen E Murphy et al. Acta Neuropathologica Communications
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, -Synuclein Accumulation, and Neurotoxicity
- (2012) M. Usenovic et al. JOURNAL OF NEUROSCIENCE
- Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration
- (2012) B. Dehay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Critical Histidine Residue Within LIMP-2 Mediates pH Sensitive Binding to Its Ligand β-Glucocerebrosidase
- (2012) Christina Zachos et al. TRAFFIC
- Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1
- (2012) Derya R. Shimshek et al. Scientific Reports
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity
- (2011) David Ramonet et al. HUMAN MOLECULAR GENETICS
- A mutation in SCARB2 is a modifier in gaucher disease
- (2011) Arash Velayati et al. HUMAN MUTATION
- α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases
- (2011) Thai Leong Yap et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models
- (2011) Y.H. Xu et al. MOLECULAR GENETICS AND METABOLISM
- Parkinson's disease and α-synuclein expression
- (2011) Michael J. Devine et al. MOVEMENT DISORDERS
- Neuropathology in Mice Expressing Mouse Alpha-Synuclein
- (2011) Claus Rieker et al. PLoS One
- Exploring the link between glucocerebrosidase mutations and parkinsonism
- (2011) Wendy Westbroek et al. TRENDS IN MOLECULAR MEDICINE
- Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease
- (2011) Chuong B. Do et al. PLoS Genetics
- Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome
- (2010) A. S. Al-Din et al. ACTA NEUROLOGICA SCANDINAVICA
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
- (2010) Ozlem Goker-Alpan et al. ACTA NEUROPATHOLOGICA
- Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
- (2010) Y. Sun et al. HUMAN MOLECULAR GENETICS
- Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease
- (2010) I. Ron et al. HUMAN MOLECULAR GENETICS
- Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease
- (2010) Suzanne Lesage et al. HUMAN MOLECULAR GENETICS
- Ultrasensitive in situ visualization of active glucocerebrosidase molecules
- (2010) Martin D Witte et al. Nature Chemical Biology
- Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy
- (2010) Kiren Ubhi et al. NEUROREPORT
- SCARB2mutations in progressive myoclonus epilepsy (PME) without renal failure
- (2009) L.M. Dibbens et al. ANNALS OF NEUROLOGY
- Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand β-glucocerebrosidase
- (2009) Judith Blanz et al. HUMAN MOLECULAR GENETICS
- Specific saposin C deficiency: CNS impairment and acid -glucosidase effects in the mouse
- (2009) Y. Sun et al. HUMAN MOLECULAR GENETICS
- Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
- (2009) Amy B. Manning-Boğ et al. NEUROTOXICOLOGY
- Array-Based Gene Discovery with Three Unrelated Subjects Shows SCARB2/LIMP-2 Deficiency Causes Myoclonus Epilepsy and Glomerulosclerosis
- (2008) Samuel F. Berkovic et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated Species†
- (2008) Daniel Sevlever et al. BIOCHEMISTRY
- Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in α-mannosidosis mice
- (2008) Judith Blanz et al. HUMAN MOLECULAR GENETICS
- A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome
- (2008) A. Balreira et al. HUMAN MOLECULAR GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started